Search hospitals
>
Wisconsin
>
Marshfield
Marshfield Medical Center-Marshfield
Claim this profile
Marshfield, Wisconsin 54449
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Lymphoma
Conducts research for Brain Tumor
441 reported clinical trials
28 medical researchers
Summary
Marshfield Medical Center-Marshfield is a medical facility located in Marshfield, Wisconsin. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Lymphoma, Brain Tumor and other specialties. Marshfield Medical Center-Marshfield is involved with conducting 441 clinical trials across 809 conditions. There are 28 research doctors associated with this hospital, such as Michelle A. Manalang, Seth O. Fagbemi, Jon M. Brandt, and Adedayo A. Onitilo.
Area of expertise
Breast Cancer
Marshfield Medical Center-Marshfield has run 75 trials for Breast Cancer. Some of their research focus areas include:
Cancer
Marshfield Medical Center-Marshfield has run 74 trials for Cancer. Some of their research focus areas include:
Top PIs
Michelle A. Manalang
Marshfield Medical Center-Marshfield
6 years of reported clinical research
Seth O. Fagbemi
Marshfield Medical Center-EC Cancer Center
2 years of reported clinical research
Jon M. Brandt
Marshfield Medical Center-Marshfield
8 years of reported clinical research
Adedayo A. Onitilo
Marshfield Medical Center-Marshfield
2 years of reported clinical research
Clinical Trials running at Marshfield Medical Center-Marshfield
Lung Cancer
Breast Cancer
Prostate Cancer
Skin Cancer
Breast cancer
Pancreatic Cancer
Multiple Myeloma
Esophageal cancer
Testicular cancer
Ovarian Cancer
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting
2 awards
Phase 3
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting
2 awards
Phase 3
4 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting
2 awards
Phase 3
14 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Marshfield Medical Center-Marshfield?
Marshfield Medical Center-Marshfield is a medical facility located in Marshfield, Wisconsin. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Lymphoma, Brain Tumor and other specialties. Marshfield Medical Center-Marshfield is involved with conducting 441 clinical trials across 809 conditions. There are 28 research doctors associated with this hospital, such as Michelle A. Manalang, Seth O. Fagbemi, Jon M. Brandt, and Adedayo A. Onitilo.
Where is Marshfield Medical Center-Marshfield located?
**Marshfield Medical Center-Marshfield** - **Address:** 1000 N Oak Ave, Marshfield, WI. - **Directions:** Take the I-94 W and US-51 N to N Central Ave in Marshfield. Head north on N Central Ave and turn right onto W 14th St.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Marshfield Medical Center-Marshfield, contact: - **Phone:** 1-800-782-8581, ext. 9-4475 - **Email:** PACCounselorShared@marshfieldclinic.org - **Address:** Marshfield Clinic Health System Patient Assistance Center, 3Q4 1000 North Oak Avenue Marshfield, WI 54449 For insurance-related inquiries, please refer to the hospital's website for direct contact information.
What insurance does Marshfield Medical Center-Marshfield accept?
Marshfield Medical Center-Marshfield accepts a wide range of insurance plans, including but not limited to HealthPartners, Humana, Network Health, and United Healthcare. They also accept Medicaid HMO Contracts such as Anthem Blue Cross Blue Shield of Wisconsin – BadgerCare Plus and SSI plans, Group Health Cooperative of Eau Claire – BadgerCare Plus and SSI plans, and United Healthcare – BadgerCare Plus and SSI plans, among others. It is crucial to directly verify your coverage and benefits with your insurance carrier, as limitations depend on individual and/or employer group contracts and benefit plans.
What awards or recognition has Marshfield Medical Center-Marshfield received?
Marshfield Medical Center-Marshfield, located in Wisconsin and part of the Marshfield Clinic Health System, is nationally recognized for patient-centered care by the National Committee for Quality Assurance. The Marshfield Clinic Research Institute (MCRI), a division of Marshfield Clinic, also received national recognition in 2019 for its innovative survey tool.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.